Facebook Twitter YouTube Google Plus

J.) Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective

Hedy Lee Kindler, MD
University of Chicago Medical Center

Dr. Hedy Lee Kindler is an internationally recognized authority on the treatment of malignant mesothelioma. Dr. Kindler is an Associate Professor of Medicine at the University of Chicago, where she is the Director of the Mesothelioma and Gastrointestinal Oncology Programs. She is the President of the International Mesothelioma Interest Group, the leading international scientific research organization dedicated to this disease. She is also a member of the Science Advisory Board of the Mesothelioma Foundation. Dr. Kindler chairs the Mesothelioma sub-committee of the Cancer and Leukemia Group B, a national cancer clinical trials group. Dr. Kindler’s research focuses on the investigation of novel agents for the treatment of malignant mesothelioma. She has published numerous journal articles, review articles, book chapters, and abstracts, and she lectures around the world on mesothelioma. Patients throughout the United States come to Dr. Kindler’s Mesothelioma Clinic at the University of Chicago for her expert care and to participate in her clinical trials. Dr. Kindler has been listed repeatedly in Best Doctors in America, America’s Top Doctors for Cancer, and Top Doctors in Chicago. 

Click here to view the slides for "Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective", by Hedy Kindler, MD.

To view the video presentation, click on the image below.

© 2009 Mesothelioma Applied Research Foundation, Inc. All rights reserved. 501(c)(3)

A.) Effective Advocacy and the Case for Federal Meso Research Funding

B.) State Assistance on Insurance Appeals

C.) Cancer Genetics in the Mesothelioma Family

D.) Fundraising

E.) Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

F.) Update from Across the Pond

G.) The Mesothelioma Experience: Patient and Provider Perspectives Panel

H.) Work of the Science Advisory Board

J.) Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective

K.) New Developments in Radiation Oncology: A Global Perspective

M.) Pain Management

Mesothelioma Treatment: Present & Future from a Surgeon & Research Perspective | Dr. Harvey Pass

N.) Traditional Healing with Modern Science

O.) Update on Clinical Trials and Mesothelioma Research

P.) Mesothelioma Tissue Bank

Photodynamic Therapy for Mesothelioma Treatment | Dr. Joseph Friedberg

Q.) EGFR Inhibitors for Patients with Malignant Peritoneal Mesothelioma

R.) The Use of Cytokine Inhibitors: Translational Lab Results

S.) Identifying and Targeting Aggressive Malignant Peritoneal Mesothelioma: Morphologic and Molecular Studies

T.) Treatment Options for Patients with Recurrent Disease after HIPEC, HRA - Panel Discussion